ARTA
VNDA icon

A.R.T. Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

A.R.T. Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-42,297
Closed -$562K – 1757
2019
Q3 		$562K Buy
+42,297
New +$589K 0.03% 808
2018
Q4 		– Sell
-48,810
Closed -$1.12M – 1682
2018
Q3 		$1.12M Buy
48,810
+20,400
+72% +$416K 0.05% 534
2018
Q2 		$541K Sell
28,410
-31,100
-52% -$520K 0.02% 886
2018
Q1 		$1M Buy
+59,510
New +$996K 0.04% 666
2017
Q4 		– Sell
-59,900
Closed -$1.07M – 1692
2017
Q3 		$1.07M Buy
59,900
+31,400
+110% +$525K 0.05% 503
2017
Q2 		$464K Sell
28,500
-50,500
-64% -$728K 0.02% 837
2017
Q1 		$1.11M Buy
79,000
+30,900
+64% +$440K 0.05% 520
2016
Q4 		$767K Buy
48,100
+33,500
+229% +$539K 0.05% 579
2016
Q3 		$242K Buy
+14,600
New +$197K 0.08% 419
2016
Q1 		– Sell
-34,352
Closed -$319K – 1677
2015
Q4 		$319K Buy
+34,352
New +$343K 0.02% 1036
2015
Q2 		– Sell
-43,406
Closed -$403K – 1732
2015
Q1 		$403K Buy
43,406
+30,107
+226% +$340K 0.01% 994
2014
Q4 		$190K Buy
+13,299
New +$157K 0.01% 1234
2013
Q4 		– Sell
-132,693
Closed -$1.45M – 1530
2013
Q3 		$1.45M Buy
132,693
+29,926
+29% +$320K 0.08% 375
2013
Q2 		$830K Buy
+102,767
New +$692K 0.03% 697

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

A.R.T. Advisors's VNDA Position: Q4 2019 in Review

A.R.T. Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q4 2019, closing a stake of 42,297 shares — an estimated $562K sold.

A.R.T. Advisors first reported a position in VNDA in Q2 2013 and held it in 14 quarters. The position peaked at $1.45M in Q3 2013. 179 funds tracked by Wall St. Rank hold VNDA as of Q4 2019.

  • A.R.T. Advisors reported no remaining Vanda Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 42,297 Vanda Pharmaceuticals shares in Q4 2019, an estimated $562K.
  • A.R.T. Advisors first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • A.R.T. Advisors's Vanda Pharmaceuticals position peaked at $1.45M in Q3 2013.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.